-transparent.png){kind=logo}
We investigated the mechanism of dissociation of cortisol and dehydroepiandrosterone sulfate (DHEA-S) secretion by the adrenal glands after the removal of an adrenal gland containing an adrenocortical adenoma in a patient with Cushing's syndrome. After removal of the adrenocortical adenoma, the serum cortisol rapidly decreased from 24.6 +/- 6.4 micrograms/dl (mean +/- SD, n = 6) to 0.7 +/- 0.5 micrograms/dl. Serum DHEA-S levels were 15 +/- 14 micrograms/dl and 6 +/- 9 micrograms/dl before and after surgery, respectively, and significantly lower than the control values. Serum cortisol levels reverted to normal levels 1.5 to 3 years after the surgery. On the other hand, DHEA-S levels reverted to normal 5 to 7 years after the serum cortisol levels had normalized. Monolayer cultures of normal human adrenal cells obtained at adrenalectomy in patients with advanced breast cancer and atrophic adrenal cells adjacent to the adrenocortical adenoma in patients with Cushing's syndrome were used to study the mechanism of the dissociation of cortisol and DHEA-S secretion. ACTH caused significant increases in the productions of pregnenolone (P5), progesterone (P4), 17-hydroxypregnenolone (17-OH-P5), 17-hydroxyprogesterone (17-OH-P4), DHEA, DHEA-S, androstenedione (delta 4-A), and cortisol. The amounts of 17-OH-P5 and 17-OH-P4 produced by ACTH in atrophic adrenal cells were significantly greater than those in normal adrenal cells. The amounts of DHEA, DHEA-S and delta 4-A produced by ACTH in atrophic adrenal cells were significantly smaller than those of normal adrenal cells. The conversion rate of 17-OH-[3H]P5 to 17-OH-[3H]P4 and 11-deoxy-[3H] cortisol was higher in atrophic adrenal cells than in normal adrenal cells, but the conversion rate to [3H]DHEA, [3H]DHEA-S and [3H]delta 4-A was significantly lower in atrophic adrenal cells than in normal adrenal cells. These results suggest that the dissociation of cortisol from DHEA-S after the removal of adrenocortical adenoma is a probably due to diminished C17,20-lyase activity in the remaining atrophic adrenal gland.
H Nawata, and
K Higuchi, and
T Yanase, and
R Takayanagi, and
K Kato, and
H Ibayashi
December 1994,
Clinical endocrinology,
H Nawata, and
K Higuchi, and
T Yanase, and
R Takayanagi, and
K Kato, and
H Ibayashi
April 1954,
Proceedings of the Royal Society of Medicine,
H Nawata, and
K Higuchi, and
T Yanase, and
R Takayanagi, and
K Kato, and
H Ibayashi
October 1979,
The Journal of clinical endocrinology and metabolism,
H Nawata, and
K Higuchi, and
T Yanase, and
R Takayanagi, and
K Kato, and
H Ibayashi
April 1988,
Endocrinologia japonica,
H Nawata, and
K Higuchi, and
T Yanase, and
R Takayanagi, and
K Kato, and
H Ibayashi
April 1995,
Endocrine journal,
H Nawata, and
K Higuchi, and
T Yanase, and
R Takayanagi, and
K Kato, and
H Ibayashi
May 1971,
The Journal of clinical endocrinology and metabolism,
H Nawata, and
K Higuchi, and
T Yanase, and
R Takayanagi, and
K Kato, and
H Ibayashi
February 1984,
Clinical endocrinology,
H Nawata, and
K Higuchi, and
T Yanase, and
R Takayanagi, and
K Kato, and
H Ibayashi
March 1956,
Surgery,
H Nawata, and
K Higuchi, and
T Yanase, and
R Takayanagi, and
K Kato, and
H Ibayashi
January 1986,
Acta pathologica japonica,
H Nawata, and
K Higuchi, and
T Yanase, and
R Takayanagi, and
K Kato, and
H Ibayashi
September 1997,
Clinical endocrinology,
